Michael F. Wangler

8.4k total citations
62 papers, 1.8k citations indexed

About

Michael F. Wangler is a scholar working on Molecular Biology, Genetics and Clinical Biochemistry. According to data from OpenAlex, Michael F. Wangler has authored 62 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 25 papers in Genetics and 8 papers in Clinical Biochemistry. Recurrent topics in Michael F. Wangler's work include Genomics and Rare Diseases (15 papers), Peroxisome Proliferator-Activated Receptors (15 papers) and Genetics and Neurodevelopmental Disorders (10 papers). Michael F. Wangler is often cited by papers focused on Genomics and Rare Diseases (15 papers), Peroxisome Proliferator-Activated Receptors (15 papers) and Genetics and Neurodevelopmental Disorders (10 papers). Michael F. Wangler collaborates with scholars based in United States, Canada and China. Michael F. Wangler's co-authors include Hugo J. Bellen, Shinya Yamamoto, Michael R. DeBaun, Andrew P. Feinberg, Aimee S. Chang, Kelle H. Moley, Ann B. Moser, Nancy Braverman, Hsiao‐Tuan Chao and Louis J. Muglia and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Nature Reviews Genetics.

In The Last Decade

Michael F. Wangler

60 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael F. Wangler United States 25 1.0k 526 288 202 176 62 1.8k
Anthi Drousiotou Cyprus 14 465 0.5× 368 0.7× 150 0.5× 109 0.5× 80 0.5× 47 1.1k
Paul J. Benke United States 24 2.0k 1.9× 828 1.6× 348 1.2× 307 1.5× 278 1.6× 54 3.0k
Neslihan Önenli Mungan Türkiye 15 511 0.5× 425 0.8× 75 0.3× 139 0.7× 93 0.5× 97 1.4k
Nobutake Matsuo Japan 32 1.5k 1.4× 1.2k 2.3× 387 1.3× 138 0.7× 105 0.6× 107 3.2k
Laurie D. Smith United States 19 467 0.5× 482 0.9× 136 0.5× 154 0.8× 113 0.6× 40 1.1k
Gerald L. Feldman United States 33 1.5k 1.4× 1.0k 1.9× 442 1.5× 257 1.3× 182 1.0× 118 3.5k
Alison Gardner Australia 17 799 0.8× 569 1.1× 194 0.7× 84 0.4× 143 0.8× 30 1.6k
Ruti Parvari Israel 28 1.2k 1.2× 831 1.6× 94 0.3× 77 0.4× 95 0.5× 88 2.7k
Sandra A. Farrell Canada 25 559 0.5× 635 1.2× 479 1.7× 37 0.2× 120 0.7× 57 1.6k
Toshiro Nagai Japan 33 2.0k 1.9× 1.8k 3.3× 616 2.1× 92 0.5× 183 1.0× 138 3.5k

Countries citing papers authored by Michael F. Wangler

Since Specialization
Citations

This map shows the geographic impact of Michael F. Wangler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael F. Wangler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael F. Wangler more than expected).

Fields of papers citing papers by Michael F. Wangler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael F. Wangler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael F. Wangler. The network helps show where Michael F. Wangler may publish in the future.

Co-authorship network of co-authors of Michael F. Wangler

This figure shows the co-authorship network connecting the top 25 collaborators of Michael F. Wangler. A scholar is included among the top collaborators of Michael F. Wangler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael F. Wangler. Michael F. Wangler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eberl, Daniel F., Güney Bademci, Stephanie Bivona, et al.. (2025). De novo variants in CDKL1 and CDKL2 are associated with neurodevelopmental symptoms. The American Journal of Human Genetics. 112(4). 846–862. 1 indexed citations
2.
Wangler, Michael F., et al.. (2023). Dicarboxylic acylcarnitine biomarkers in peroxisome biogenesis disorders. Molecular Genetics and Metabolism. 140(3). 107680–107680. 3 indexed citations
3.
Littlejohn, Rebecca O., et al.. (2023). Precision therapy for a medically actionable ATP1A3 variant from a genomic medicine program in an underserved population. Molecular Genetics & Genomic Medicine. 11(12). e2272–e2272. 1 indexed citations
4.
Briere, Lauren C., Melissa Walker, Lance H. Rodan, et al.. (2023). A de novo missense variant in EZH1 associated with developmental delay exhibits functional deficits in Drosophila melanogaster. Genetics. 224(4). 6 indexed citations
5.
Li, Xiqi, Lindsay C. Burrage, Kevin Riehle, et al.. (2022). Clinical diagnosis of metabolic disorders using untargeted metabolomic profiling and disease-specific networks learned from profiling data. Scientific Reports. 12(1). 6556–6556. 18 indexed citations
6.
Lu, Shenzhao, Mengqi Ma, Xiao Mao, et al.. (2022). De novo variants in FRMD5 are associated with developmental delay, intellectual disability, ataxia, and abnormalities of eye movement. The American Journal of Human Genetics. 109(10). 1932–1943. 9 indexed citations
7.
Graves, Hillary K., Kai Li Tan, Antonella Pignata, et al.. (2019). A Genetic Screen for Genes That Impact Peroxisomes in Drosophila Identifies Candidate Genes for Human Disease. G3 Genes Genomes Genetics. 10(1). 69–77. 7 indexed citations
8.
Batzir, Nurit Assia, Tanya N. Eble, Pengfei Liu, et al.. (2019). De novo missense variant in the GTPase effector domain (GED) of DNM1L leads to static encephalopathy and seizures. Molecular Case Studies. 5(3). a003673–a003673. 26 indexed citations
9.
Murdock, David R., Yunyun Jiang, Michael F. Wangler, et al.. (2019). Xia–Gibbs syndrome in adulthood: a case report with insight into the natural history of the condition. Molecular Case Studies. 5(3). a003608–a003608. 13 indexed citations
10.
Wangler, Michael F., Vafa Bayat, Νικόλαος Γιαγτζόγλου, et al.. (2017). Peroxisomal biogenesis is genetically and biochemically linked to carbohydrate metabolism in Drosophila and mouse. PLoS Genetics. 13(6). e1006825–e1006825. 32 indexed citations
11.
Wangler, Michael F., Shinya Yamamoto, Hsiao‐Tuan Chao, et al.. (2017). Model Organisms Facilitate Rare Disease Diagnosis and Therapeutic Research. Genetics. 207(1). 9–27. 131 indexed citations
12.
Halim, Danny, Erwin Brosens, Françoise Müller, et al.. (2017). Loss-of-Function Variants in MYLK Cause Recessive Megacystis Microcolon Intestinal Hypoperistalsis Syndrome. The American Journal of Human Genetics. 101(1). 123–129. 52 indexed citations
13.
Wheaton, Dianna K., Mingchu Xu, David G. Birch, et al.. (2016). Diagnosis of a mild peroxisomal phenotype with next-generation sequencing. Molecular Genetics and Metabolism Reports. 9. 75–78. 27 indexed citations
14.
Wangler, Michael F., Shinya Yamamoto, & Hugo J. Bellen. (2015). Fruit Flies in Biomedical Research. Genetics. 199(3). 639–653. 124 indexed citations
15.
Braverman, Nancy, Gerald V. Raymond, William B. Rizzo, et al.. (2015). Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines. Molecular Genetics and Metabolism. 117(3). 313–321. 177 indexed citations
16.
Wangler, Michael F. & Arthur L. Beaudet. (2015). ACTG2-Related Disorders. Europe PMC (PubMed Central). 7 indexed citations
17.
Landsverk, Megan, Timothy Lotze, Jill V. Hunter, et al.. (2011). Atypical presentation of Leigh syndrome associated with a Leber hereditary optic neuropathy primary mitochondrial DNA mutation. Molecular Genetics and Metabolism. 103(2). 153–160. 20 indexed citations
18.
Wangler, Michael F., et al.. (2011). Antioxidant proteins TSA and PAG interact synergistically with Presenilin to modulate Notch signaling in Drosophila. Protein & Cell. 2(7). 554–563. 1 indexed citations
19.
Wangler, Michael F., Ping An, Andrew P. Feinberg, Michael A. Province, & Michael R. DeBaun. (2005). Inheritance pattern of Beckwith–Wiedemann syndrome is heterogeneous in 291 families with an affected proband. American Journal of Medical Genetics Part A. 137A(1). 16–21. 8 indexed citations
20.
Chang, Aimee S., Kelle H. Moley, Michael F. Wangler, Andrew P. Feinberg, & Michael R. DeBaun. (2005). Association between Beckwith-Wiedemann syndrome and assisted reproductive technology: A case series of 19 patients. Fertility and Sterility. 83(2). 349–354. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anthi Drousiotou Breakdown of academic impact, for papers by Paul J. Benke Breakdown of academic impact, for papers by Neslihan Önenli Mungan Breakdown of academic impact, for papers by Nobutake Matsuo Breakdown of academic impact, for papers by Laurie D. Smith Breakdown of academic impact, for papers by Gerald L. Feldman Breakdown of academic impact, for papers by Alison Gardner Breakdown of academic impact, for papers by Ruti Parvari Breakdown of academic impact, for papers by Sandra A. Farrell Breakdown of academic impact, for papers by Toshiro Nagai
Rankless by CCL
2026